Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 1.555
+0.035 (2.30%)
Oct 10, 2025, 4:54 PM CET
Stenocare Market Cap
Stenocare has a market cap or net worth of 59.39 million as of October 10, 2025. Its market cap has increased by 30.38% in one year.
Market Cap
59.39M
Enterprise Value
57.36M
Revenue
2.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.56
Market Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 59.39M, a decrease of -81.83%. That is a compound annual growth rate of -27.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 59.39M | 128.67% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | 223.96M | -31.48% |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,674.95B |
| Coloplast | 127.35B |
| Genmab | 125.82B |
| Demant | 48.52B |
| ALK-Abelló | 47.16B |
| H. Lundbeck | 43.39B |
| Zealand Pharma | 35.07B |
| Ambu A/S | 27.46B |